John M. Burke, MD, discusses the influence of two key BTK inhibitor combination studies on therapeutic approaches for patients with previously untreated mantle cell lymphoma.
It’s been over a year since Dillon resident John Melott faced a devastating reality: as a healthy 27-year-old, he had a life-threatening form of blood cancer. Melott, now 29, is in remission. It can still.
A new report from the American Cancer Society found colorectal cancer is affecting younger individuals and they're being diagnosed with more advanced stages of the disease.